121 related articles for article (PubMed ID: 3378383)
1. The use of serum methadone levels in patients receiving methadone maintenance.
Bell J; Seres V; Bowron P; Lewis J; Batey R
Clin Pharmacol Ther; 1988 Jun; 43(6):623-9. PubMed ID: 3378383
[TBL] [Abstract][Full Text] [Related]
2. Serum methadone as an aid in managing methadone maintenance patients.
Walton RG; Thornton TL; Wahl GF
Int J Addict; 1978 Jul; 13(5):689-94. PubMed ID: 721328
[TBL] [Abstract][Full Text] [Related]
3. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
[TBL] [Abstract][Full Text] [Related]
4. Methadone trough levels in pregnancy.
Drozdick J; Berghella V; Hill M; Kaltenbach K
Am J Obstet Gynecol; 2002 Nov; 187(5):1184-8. PubMed ID: 12439500
[TBL] [Abstract][Full Text] [Related]
5. Methadone dosage, program policies, and heroin use among methadone patients.
Newman RG; Des Jarlais DC
J Subst Abuse Treat; 1992; 9(2):183-4. PubMed ID: 1512805
[No Abstract] [Full Text] [Related]
6. [Methadone treatment and its dangers].
Reingardiene D; Jodziūniene L; Lazauskas R
Medicina (Kaunas); 2009; 45(5):419-25. PubMed ID: 19535889
[TBL] [Abstract][Full Text] [Related]
7. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
[TBL] [Abstract][Full Text] [Related]
8. Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.
Liu SJ; Wang RI
Am J Psychiatry; 1984 Oct; 141(10):1287-8. PubMed ID: 6486271
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride.
Horns WH; Rado M; Goldstein A
Clin Pharmacol Ther; 1975 Jun; 17(6):636-49. PubMed ID: 1139855
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal from methadone maintenance. Impact of a tapering network support program.
Sorensen JL; Trier M; Brummett S; Gold ML; Dumontet R
J Subst Abuse Treat; 1992; 9(1):21-6. PubMed ID: 1593661
[TBL] [Abstract][Full Text] [Related]
11. Methadone dose and heroin use during maintenance treatment.
Caplehorn JR; Bell J; Kleinbaum DG; Gebski VJ
Addiction; 1993 Jan; 88(1):119-24. PubMed ID: 8448501
[TBL] [Abstract][Full Text] [Related]
12. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
[TBL] [Abstract][Full Text] [Related]
13. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
[TBL] [Abstract][Full Text] [Related]
14. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
[TBL] [Abstract][Full Text] [Related]
15. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
[TBL] [Abstract][Full Text] [Related]
16. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
[TBL] [Abstract][Full Text] [Related]
17. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
[TBL] [Abstract][Full Text] [Related]
18. Availability of reliable serum methadone determination for management of symptomatic patients.
Borg L; Ho A; Peters JE; Kreek MJ
J Addict Dis; 1995; 14(3):83-96. PubMed ID: 8555281
[TBL] [Abstract][Full Text] [Related]
19. Methadone dosages and therapeutic compliance during a methadone maintenance program.
Maremmani I; Nardini R; Zolesi O; Castrogiovanni P
Drug Alcohol Depend; 1994 Jan; 34(2):163-6. PubMed ID: 8026304
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin and prolactin serum levels in heroin addicts: study on a methadone treated group.
Spagnolli W; Torboli P; Mattarei M; De Venuto G; Marcolla A; Miori R
Drug Alcohol Depend; 1987 Nov; 20(2):143-8. PubMed ID: 3678052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
